KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Current Deferred Revenue (2016 - 2025)

Nu Skin Enterprises' Current Deferred Revenue history spans 11 years, with the latest figure at $12.7 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 18.81% year-over-year to $12.7 million; the TTM value through Dec 2025 reached $12.7 million, down 18.81%, while the annual FY2025 figure was $12.7 million, 18.81% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $12.7 million at Nu Skin Enterprises, down from $15.7 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $33.1 million in Q4 2021 and bottomed at $12.7 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $20.3 million (2023), against an average of $21.8 million.
  • The largest annual shift saw Current Deferred Revenue decreased 5.46% in 2021 before it dropped 24.82% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $33.1 million in 2021, then dropped by 18.37% to $27.1 million in 2022, then decreased by 24.82% to $20.3 million in 2023, then dropped by 22.86% to $15.7 million in 2024, then decreased by 18.81% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Current Deferred Revenue are $12.7 million (Q4 2025), $15.7 million (Q4 2024), and $20.3 million (Q4 2023).